Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Sellas claims Phase 3 win on AML cancer vaccine

Sellas Life Sciences' cancer vaccine succeeded in a Phase 3 trial of certain acute myeloid leukemia patients, the company said Tuesday. Sellas is developing galinpepimut-S, which it calls GPS for short ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 17 November →